{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:07:28Z","timestamp":1794280048375,"version":"4.9.0"},"reference-count":62,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Otolaryngol Head Neck Surg"],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:sec id=\"ab-orv260003-1\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Obstructive sleep apnea (OSA) affects nearly 1 billion adults worldwide and is independently associated with cardiovascular disease, stroke, and increased mortality. While continuous positive airway pressure (CPAP) remains the criterion standard treatment, adherence rates of only 30% to 60% limit its population-level effectiveness. Obesity is present in 60% to 70% of patients with OSA and represents the primary modifiable risk factor, yet, until recently, no pharmacological therapies specifically targeted this pathophysiological mechanism. The December 2024 US Food and Drug Administration approval of tirzepatide as the first medication indicated for moderate to severe OSA in adults with obesity represents a paradigm shift toward disease-modifying pharmacotherapy, with implications for otolaryngologic practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-orv260003-2\">\n                    <jats:title>Observations<\/jats:title>\n                    <jats:p>Six meta-analyses demonstrated consistent apnea-hypopnea index (AHI) reductions with glucagon-like peptide-1 receptor agonists (GLP-1 RAs), ranging from \u22125.7 to \u221221.9 events per hour. The SURMOUNT-OSA phase 3 trials showed that tirzepatide reduced AHI by 20 to 24 events per hour vs placebo, with 42% to 50% of patients experiencing disease remission (AHI, &amp;amp;lt;5 events per hour or &amp;amp;lt;15 without symptoms). Weight loss is the primary established mechanism, with GLP-1 RAs reducing tongue fat and parapharyngeal adipose tissue that contribute to upper airway collapse. Emerging preclinical evidence has suggested potential weight-independent effects through carotid body glucagon-like peptide 1 receptor modulation of chemosensitivity (affecting loop gain), leptin pathway interactions that are associated with upper airway neuromuscular control, and NLRP3 inflammasome suppression. However, GLP-1 RAs did not match CPAP efficacy (approximately22 vs 31 events per hour of an AHI reduction), cardiovascular outcome benefits remain unproven, and weight regain commonly occurs after discontinuation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-orv260003-3\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>This review suggest that GLP-1 RAs offer otolaryngologists a disease-modifying adjunct for obesity-related OSA that is best positioned as complementary therapy alongside CPAP, preoperative optimization before upper airway surgery, or potentially to expand hypoglossal nerve stimulator candidacy. They are appropriate for patients with a body mass index (calculated as weight in kilograms divided by height in meters squared) greater than 30 who are CPAP-intolerant or have obesity-related comorbidities but are unlikely to benefit individuals without obesity or those with primarily anatomical obstruction. Critical evidence gaps include associations with pharyngeal critical closing pressure, drug-induced sleep endoscopy collapse patterns, and hypoglossal nerve stimulator combination therapy outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaoto.2026.2266","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:03:53Z","timestamp":1788451433000},"page":"992","source":"Crossref","is-referenced-by-count":1,"title":["Glucagon-Like Peptide-1 Receptor Agonists for Obstructive Sleep Apnea"],"prefix":"10.1001","volume":"152","author":[{"given":"Alexandria","family":"Harris","sequence":"first","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kaffenberger","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"orv260003r1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S2213-2600(19)30198-5","article-title":"Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis.","volume":"7","author":"Benjafield","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"9464","key":"orv260003r2","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/S0140-6736(05)71141-7","article-title":"Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.","volume":"365","author":"Marin","year":"2005","journal-title":"Lancet"},{"issue":"8","key":"orv260003r3","first-page":"1071","article-title":"Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort.","volume":"31","author":"Young","year":"2008","journal-title":"Sleep"},{"issue":"2","key":"orv260003r4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5664\/jcsm.7640","article-title":"Treatment of adult obstructive sleep apnea with positive airway pressure: an American Academy of Sleep Medicine clinical practice guideline.","volume":"15","author":"Patil","year":"2019","journal-title":"J Clin Sleep Med"},{"issue":"2","key":"orv260003r5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1513\/pats.200708-119MG","article-title":"Adherence to continuous positive airway pressure therapy: the challenge to effective treatment.","volume":"5","author":"Weaver","year":"2008","journal-title":"Proc Am Thorac Soc"},{"issue":"3","key":"orv260003r6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1378\/chest.09-0360","article-title":"Interactions between obesity and obstructive sleep apnea: implications for treatment.","volume":"137","author":"Romero-Corral","year":"2010","journal-title":"Chest"},{"issue":"2","key":"orv260003r7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1513\/pats.200708-137MG","article-title":"Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches.","volume":"5","author":"Schwartz","year":"2008","journal-title":"Proc Am Thorac Soc"},{"issue":"8","key":"orv260003r8","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1164\/rccm.201303-0448OC","article-title":"Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets.","volume":"188","author":"Eckert","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"23","key":"orv260003r9","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1001\/jama.284.23.3015","article-title":"Longitudinal study of moderate weight change and sleep-disordered breathing.","volume":"284","author":"Peppard","year":"2000","journal-title":"JAMA"},{"issue":"24","key":"orv260003r10","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1056\/NEJMoa1306187","article-title":"CPAP, weight loss, or both for obstructive sleep apnea.","volume":"370","author":"Chirinos","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"orv260003r11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.5664\/jcsm.6394","article-title":"Obstructive sleep apnea without obesity is common and difficult to treat: evidence for a distinct pathophysiological phenotype.","volume":"13","author":"Gray","year":"2017","journal-title":"J Clin Sleep Med"},{"key":"orv260003r12","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103221","article-title":"The relationship between obesity and obstructive sleep apnea in four community-based cohorts: an individual participant data meta-analysis of 12,860 adults.","volume":"83","author":"Esmaeili","year":"2025","journal-title":"EClinicalMedicine"},{"issue":"8","key":"orv260003r13","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1001\/jama.2024.28055","article-title":"FDA approves tirzepatide as first drug for obstructive sleep apnea.","volume":"333","author":"Anderer","year":"2025","journal-title":"JAMA"},{"issue":"3","key":"orv260003r14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity.","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"orv260003r15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA\u2014a scale for the quality assessment of narrative review articles.","volume":"4","author":"Baethge","year":"2019","journal-title":"Res Integr Peer Rev"},{"issue":"8","key":"orv260003r16","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/ijo.2016.52","article-title":"Effect of liraglutide 3.0?mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial.","volume":"40","author":"Blackman","year":"2016","journal-title":"Int J Obes (Lond)"},{"issue":"6","key":"orv260003r17","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1164\/rccm.201903-0692OC","article-title":"Effect of weight loss on upper airway anatomy and the Apnea-Hypopnea Index: the importance of tongue fat.","volume":"201","author":"Wang","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"orv260003r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.108935","article-title":"Semaglutide reduces fat accumulation in the tongue: a randomized single-blind, pilot study.","volume":"178","author":"Jensterle","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"orv260003r19","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s11325-022-02734-8","article-title":"The effect of surgical weight loss on upper airway fat in obstructive sleep apnoea.","volume":"27","author":"Sutherland","year":"2023","journal-title":"Sleep Breath"},{"issue":"533","key":"orv260003r20","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay8071","article-title":"GABA neurons in the nucleus tractus solitarius express GLP-1 receptors and mediate anorectic effects of liraglutide in rats.","volume":"12","author":"Fortin","year":"2020","journal-title":"Sci Transl Med"},{"issue":"4","key":"orv260003r21","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s42255-021-00363-1","article-title":"A genetic map of the mouse dorsal vagal complex and its role in obesity.","volume":"3","author":"Ludwig","year":"2021","journal-title":"Nat Metab"},{"issue":"1","key":"orv260003r22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1172\/JCI0215595","article-title":"Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons.","volume":"110","author":"Yamamoto","year":"2002","journal-title":"J Clin Invest"},{"issue":"1","key":"orv260003r23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1152\/physrev.00043.2008","article-title":"Pathophysiology of sleep apnea.","volume":"90","author":"Dempsey","year":"2010","journal-title":"Physiol Rev"},{"issue":"8","key":"orv260003r24","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1164\/rccm.201404-0783OC","article-title":"Enhanced upper-airway muscle responsiveness is a distinct feature of overweight\/obese individuals without sleep apnea.","volume":"190","author":"Sands","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"orv260003r25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2024.107516","article-title":"Tirzepatide for the treatment of obstructive sleep apnea: rationale, design, and sample baseline characteristics of the SURMOUNT-OSA phase 3 trial.","volume":"141","author":"Malhotra","year":"2024","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"orv260003r26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/j.2040-4603.2012.tb00399.x","article-title":"Peripheral chemoreceptors: function and plasticity of the carotid body.","volume":"2","author":"Kumar","year":"2012","journal-title":"Compr Physiol"},{"issue":"5","key":"orv260003r27","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1161\/CIRCRESAHA.121.319874","article-title":"GLP1R attenuates sympathetic response to high glucose via carotid body inhibition.","volume":"130","author":"Pauza","year":"2022","journal-title":"Circ Res"},{"issue":"6","key":"orv260003r28","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/MCP.0000000000001208","article-title":"Glucagon-like peptide-1 receptor agonists for the treatment of obstructive sleep apnea.","volume":"31","author":"D\u2019Annibale","year":"2025","journal-title":"Curr Opin Pulm Med"},{"issue":"3 Pt 1","key":"orv260003r29","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1164\/ajrccm\/144.3_Pt_1.494","article-title":"Effect of weight loss on upper airway collapsibility in obstructive sleep apnea.","volume":"144","author":"Schwartz","year":"1991","journal-title":"Am Rev Respir Dis"},{"issue":"5","key":"orv260003r30","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.neuron.2015.08.001","article-title":"Neural control of breathing and CO2 homeostasis.","volume":"87","author":"Guyenet","year":"2015","journal-title":"Neuron"},{"issue":"5","key":"orv260003r31","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.5665\/sleep.5762","article-title":"Localizing effects of leptin on upper airway and respiratory control during sleep.","volume":"39","author":"Yao","year":"2016","journal-title":"Sleep"},{"issue":"9","key":"orv260003r32","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsac153","article-title":"Leptin-mediated neural targets in obesity hypoventilation syndrome.","volume":"45","author":"Amorim","year":"2022","journal-title":"Sleep"},{"issue":"4","key":"orv260003r33","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1.","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab"},{"issue":"12","key":"orv260003r34","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113512","article-title":"Leptin signaling in the dorsomedial hypothalamus couples breathing and metabolism in obesity.","volume":"42","author":"Amorim","year":"2023","journal-title":"Cell Rep"},{"issue":"6","key":"orv260003r35","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1164\/rccm.201805-0879OC","article-title":"Intranasal leptin relieves sleep-disordered breathing in mice with diet-induced obesity.","volume":"199","author":"Berger","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"orv260003r36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13395-025-00387-1","article-title":"Abnormalities in the genioglossus muscle and its neuromuscular synapse in leptin-deficient male mice.","volume":"15","author":"Medharametla","year":"2025","journal-title":"Skelet Muscle"},{"issue":"3","key":"orv260003r37","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1183\/09031936.04.00099404","article-title":"Effects of obesity upon genioglossus structure and function in obstructive sleep apnoea.","volume":"23","author":"Carrera","year":"2004","journal-title":"Eur Respir J"},{"issue":"11","key":"orv260003r38","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1164\/rccm.202106-1445OC","article-title":"Inflammasome activation: a keystone of proinflammatory response in obstructive sleep apnea.","volume":"205","author":"D\u00edaz-Garc\u00eda","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"orv260003r39","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2023.104204","article-title":"Effect of the NLRP3 inflammasome on increased hypoxic ventilation response after CIH exposure in mice.","volume":"321","author":"Jia","year":"2024","journal-title":"Respir Physiol Neurobiol"},{"issue":"2","key":"orv260003r40","doi-asserted-by":"publisher","DOI":"10.1177\/0300060521992981","article-title":"GLP-1 alleviates NLRP3 inflammasome\u2013dependent inflammation in perivascular adipose tissue by inhibiting the NF-?B signaling pathway.","volume":"49","author":"Chen","year":"2021","journal-title":"J Int Med Res"},{"issue":"Pt B","key":"orv260003r41","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113222","article-title":"GLP-1 analogue liraglutide attenuates CIH-induced cognitive deficits by inhibiting oxidative stress, neuroinflammation, and apoptosis via the Nrf2\/HO-1 and MAPK\/NF-?B signaling pathways.","volume":"142","author":"Lv","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"orv260003r42","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1113\/EP090536","article-title":"NADPH oxidase 2 is necessary for chronic intermittent hypoxia-induced sternohyoid muscle weakness in adult male mice.","volume":"107","author":"Drummond","year":"2022","journal-title":"Exp Physiol"},{"key":"orv260003r43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.freeradbiomed.2016.03.002","article-title":"Glucagon-like peptide-1 improves beta-cell antioxidant capacity via extracellular regulated kinases pathway and Nrf2 translocation.","volume":"95","author":"Fern\u00e1ndez-Mill\u00e1n","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"orv260003r44","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.5114\/amsad\/161170","article-title":"GLP-1 receptor agonists, SGLT-2 inhibitors, and obstructive sleep apnoea: can new allies face an old enemy?","volume":"8","author":"Papaetis","year":"2023","journal-title":"Arch Med Sci Atheroscler Dis"},{"issue":"13","key":"orv260003r45","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity.","volume":"391","author":"Malhotra","year":"2024","journal-title":"N Engl J Med"},{"key":"orv260003r46","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2025.106853","article-title":"Tirzepatide for sleep-disordered breathing in SURMOUNT-OSA: time course and association with body weight.","volume":"136","author":"Malhotra","year":"2025","journal-title":"Sleep Med"},{"issue":"3","key":"orv260003r47","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1513\/AnnalsATS.202309-821OC","article-title":"Continuous positive airway pressure but not GLP1-mediated weight loss improves early cardiovascular disease in obstructive sleep apnea: a randomized proof-of-concept study.","volume":"21","author":"O\u2019Donnell","year":"2024","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"orv260003r48","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsae280","article-title":"Glucagon-like peptide-1 receptor agonists for the treatment of obstructive sleep apnea: a meta-analysis.","volume":"48","author":"Li","year":"2025","journal-title":"Sleep"},{"issue":"1","key":"orv260003r49","doi-asserted-by":"publisher","DOI":"10.1080\/20018525.2025.2484048","article-title":"Safety and efficacy of glucagon-like peptide-1 receptor agonists in patients with obstructive sleep apnea: a systematic review and meta-analysis of randomized controlled trials.","volume":"12","author":"Altobaishat","year":"2025","journal-title":"Eur Clin Respir J"},{"issue":"1","key":"orv260003r50","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12967-025-06302-y","article-title":"Glucagon-like peptide-1 receptor agonists for obstructive sleep apnea in patients with obesity and type 2 diabetes mellitus: a systematic review and meta-analysis.","volume":"23","author":"Yang","year":"2025","journal-title":"J Transl Med"},{"key":"orv260003r51","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.sleep.2025.02.010","article-title":"Efficacy and safety of GLP-1 receptor agonists in the management of obstructive sleep apnea in individuals without diabetes: a systematic review and meta-analysis of randomized, placebo-controlled trials.","volume":"129","author":"Kow","year":"2025","journal-title":"Sleep Med"},{"key":"orv260003r52","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103529","article-title":"Effect of sleep apnoea interventions on multiple health outcomes: an umbrella review of meta-analyses of randomised controlled trials.","volume":"89","author":"Figard","year":"2025","journal-title":"EClinicalMedicine"},{"issue":"1","key":"orv260003r53","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/pharmacy12010011","article-title":"The impact of glucagon-like peptide 1 receptor agonists on obstructive sleep apnoea: a scoping review.","volume":"12","author":"Le","year":"2024","journal-title":"Pharmacy (Basel)"},{"issue":"5","key":"orv260003r54","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/lary.28286","article-title":"Results of the ADHERE upper airway stimulation registry and predictors of therapy efficacy.","volume":"130","author":"Thaler","year":"2020","journal-title":"Laryngoscope"},{"issue":"6","key":"orv260003r55","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.5664\/jcsm.10496","article-title":"Long-term trends in body mass index throughout upper airway stimulation treatment: does body mass index matter?","volume":"19","author":"Renslo","year":"2023","journal-title":"J Clin Sleep Med"},{"issue":"11","key":"orv260003r56","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1164\/rccm.201408-1498LE","article-title":"Effect of parapharyngeal fat on dynamic obstruction of the upper airway in patients with obstructive sleep apnea.","volume":"190","author":"Jang","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"orv260003r57","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11325-024-03172-4","article-title":"Predicting complete concentric collapse at the palatal level during drug-induced sleep endoscopy: an analysis of 1761 cases.","volume":"29","author":"Schoustra","year":"2024","journal-title":"Sleep Breath"},{"issue":"20","key":"orv260003r58","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.jacc.2025.08.027","article-title":"Cardiovascular effects and tolerability of GLP-1 receptor agonists: a systematic review and meta-analysis of 99,599 patients.","volume":"86","author":"Galli","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"orv260003r59","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.57349","article-title":"Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among US adults with overweight or obesity.","volume":"8","author":"Rodriguez","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"8","key":"orv260003r60","doi-asserted-by":"publisher","first-page":"860","DOI":"10.18553\/jmcp.2024.23332","article-title":"Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes.","volume":"30","author":"Gleason","year":"2024","journal-title":"J Manag Care Spec Pharm"},{"issue":"6","key":"orv260003r61","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1097\/ALN.0b013e318173f103","article-title":"Anatomical balance of the upper airway and obstructive sleep apnea.","volume":"108","author":"Tsuiki","year":"2008","journal-title":"Anesthesiology"},{"issue":"3","key":"orv260003r62","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2024.5586","article-title":"Lifetime health effects and cost-effectiveness of tirzepatide and semaglutide in US adults.","volume":"6","author":"Hwang","year":"2025","journal-title":"JAMA Health Forum"}],"container-title":["JAMA Otolaryngology\u2013Head &amp; Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/articlepdf\/2853311\/jamaotolaryngology_harris_2026_rv_260003_1791389920.83656.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:00:41Z","timestamp":1791471641000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/fullarticle\/2853311"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":62,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoto.2026.2266","relation":{},"ISSN":["2168-6181"],"issn-type":[{"value":"2168-6181","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}